Thrivent Financial for Lutherans
ALXN

Thrivent Financial for Lutherans’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-9,493
Closed -$1.74M 2539
2021
Q2
$1.74M Buy
9,493
+67
+0.7% +$12.3K ﹤0.01% 1500
2021
Q1
$1.44M Sell
9,426
-411,575
-98% -$62.9M ﹤0.01% 1626
2020
Q4
$65.8M Sell
421,001
-168,087
-29% -$26.3M 0.15% 171
2020
Q3
$67.4M Buy
589,088
+97,758
+20% +$11.2M 0.18% 135
2020
Q2
$55.1M Sell
491,330
-21,210
-4% -$2.38M 0.17% 152
2020
Q1
$46M Sell
512,540
-31,765
-6% -$2.85M 0.17% 154
2019
Q4
$58.9M Buy
544,305
+491,787
+936% +$53.2M 0.17% 166
2019
Q3
$5.14M Buy
52,518
+42,450
+422% +$4.16M 0.02% 681
2019
Q2
$1.32M Buy
10,068
+91
+0.9% +$11.9K ﹤0.01% 1230
2019
Q1
$1.35M Buy
9,977
+252
+3% +$34.1K ﹤0.01% 1176
2018
Q4
$947K Buy
9,725
+171
+2% +$16.7K ﹤0.01% 1189
2018
Q3
$1.33M Buy
9,554
+211
+2% +$29.3K ﹤0.01% 1110
2018
Q2
$1.16M Sell
9,343
-920,479
-99% -$114M ﹤0.01% 1170
2018
Q1
$104M Sell
929,822
-56,004
-6% -$6.24M 0.35% 61
2017
Q4
$118M Buy
985,826
+177,594
+22% +$21.2M 0.39% 54
2017
Q3
$113M Sell
808,232
-43,934
-5% -$6.16M 0.4% 53
2017
Q2
$104M Buy
852,166
+132,456
+18% +$16.1M 0.43% 51
2017
Q1
$87.3M Sell
719,710
-318,110
-31% -$38.6M 0.38% 63
2016
Q4
$127M Buy
1,037,820
+129,890
+14% +$15.9M 0.57% 33
2016
Q3
$111M Buy
907,930
+283,070
+45% +$34.7M 0.51% 36
2016
Q2
$73M Buy
624,860
+618,320
+9,454% +$72.2M 0.35% 71
2016
Q1
$910K Buy
6,540
+210
+3% +$29.2K ﹤0.01% 1111
2015
Q4
$1.21M Sell
6,330
-698,880
-99% -$133M 0.01% 1007
2015
Q3
$110M Sell
705,210
-72,680
-9% -$11.4M 0.58% 36
2015
Q2
$141M Buy
777,890
+336,510
+76% +$60.8M 0.78% 23
2015
Q1
$76.5M Buy
441,380
+436,680
+9,291% +$75.7M 0.42% 57
2014
Q4
$870K Sell
4,700
-26,700
-85% -$4.94M ﹤0.01% 884
2014
Q3
$5.21M Buy
31,400
+26,700
+568% +$4.43M 0.03% 455
2014
Q2
$734K Buy
4,700
+100
+2% +$15.6K ﹤0.01% 982
2014
Q1
$700K Hold
4,600
﹤0.01% 826
2013
Q4
$611K Hold
4,600
﹤0.01% 901
2013
Q3
$534K Sell
4,600
-2,200
-32% -$255K ﹤0.01% 903
2013
Q2
$627 Buy
+6,800
New +$627 ﹤0.01% 832